Well YES if they have a working vaccine/inhibitor/immune response, what do you think will happen to the sp? It will make the breast cancer announcement look like a blip IMO.
The company have already stated that there was some encouraging signs with delayed tumour growth.
The trials have a 3 pronged focus.
Reducing tumour size
Inhibiting tumour growth
Inducing an effective immune response
I'd be very very happy with encouraging results from any of the 3 and over the moon with one decent one and completely beside myself if all 3 came with great results.
I suspect the labs will be on holiday also so don't expect anything before the 7th and I suspect it could be a bit later.
If any of these 3 are showing potential the results will need to be verified and triple checked.
If none of them were doing anything I think results would have been in by now and we know from the below that there is some glimmer of encouragement in inhibiting tumour growth. AIMO DB
- Forums
- ASX - By Stock
- IIQ
- BD1 Outlook
BD1 Outlook, page-229
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.18M |
Open | High | Low | Value | Volume |
45.0¢ | 45.0¢ | 43.0¢ | $18.17K | 41.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 52546 | 43.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 24522 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 52546 | 0.435 |
2 | 6333 | 0.430 |
5 | 44773 | 0.425 |
1 | 10000 | 0.410 |
3 | 24814 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 24522 | 1 |
0.460 | 6850 | 1 |
0.465 | 1195 | 1 |
0.470 | 35663 | 2 |
0.480 | 40000 | 2 |
Last trade - 13.54pm 12/11/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online